Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-21

Clinical Trial Update: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes [Phase 2]

View source ↗

Summary

Phase 2 trial update for a new antiviral against Genital Herpes has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AiCuris Anti-infective Cures AG | Conditions: Genital Herpes | Phase 2 | Status: TERMINATED | Results posted: 2023-04-21